Mr. Dan Golden, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Center St, Healdsburg, CA 95448 Phone: 707-433-3357 |
Loreen Atallah, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1375 University Ave, Healdsburg, CA 95448 Phone: 707-431-6500 |
Mr. David Hilty, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 Fax: 707-431-1403 |
Joanna Christine Belmes Eslava, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 |
Loren K Miyasaki, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Healdsburg Ave, Healdsburg, CA 95448 Phone: 707-431-1119 Fax: 707-431-0457 |
Adrienne Tom Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 |
Dr. Lucila Contreras Saldana, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Healdsburg, CA 95448 Phone: 707-431-0128 Fax: 707-431-1403 |
Dr. Emily Wu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Center St, Healdsburg, CA 95448 Phone: 707-433-3357 |
Long Phan, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1375 University St, Healdsburg, CA 95448 Phone: 408-781-4631 |
Matthew R Chao Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Center St, Healdsburg, CA 95448 Phone: 707-433-3357 |
Mr. Martin Cablk, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Sunnyvale Dr, Healdsburg, CA 95448 Phone: 707-431-1937 |
News Archive
A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections.
The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo-) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect.
Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure.
As we testified on Nov. 1 before the Joint Select Committee on Deficit Reduction, the principal driver of long-term federal deficits is the rapidly mounting cost of healthcare, particularly Medicare. ... Solving the U.S. debt crisis requires structural changes to slow Medicare's cost growth plus significant new revenue to accommodate the retirement of the baby boomers. Any plan without those two essential components should go back to the drawing board.
› Verified 4 days ago